
-
Trump signs executive order establishing 'Strategic Bitcoin Reserve'
-
Australian casino firm scrambles for cash to survive
-
NYC High Line architect Scofidio dead at 89
-
Musk's SpaceX faces setback with new Starship upper stage loss
-
Australians told 'prepare for worst' as tropical cyclone nears
-
Clark edges two clear at Arnold Palmer Invitational
-
Super cool: ATP sensation Fonseca learning to deal with demands of fame
-
Trump again casts doubt on his commitment to NATO
-
EU leaders agree defence boost as US announces new talks with Kyiv
-
48 killed in 'most violent' Syria unrest since Assad ouster: monitor
-
US and European stocks gyrate on tariffs and growth
-
Deja vu on the Moon: Private US spaceship again lands awkwardly
-
Brazilian teen Fonseca into Indian Wells second round
-
Abortion access under threat in Milei's Argentina
-
Trump backs off Mexico, Canada tariffs after market blowback
-
Trump car tariff pivot and Detroit's 'Big Three'
-
Man Utd draw in Spain in Europa League last 16 as Spurs beaten
-
California's Democratic governor says trans women in sports 'unfair'
-
Trump says Musk should use 'scalpel' not 'hatchet' in govt cuts
-
Goodall, Shatner to receive environmentalist awards from Sierra Club
-
Dingwall glad to be 'the glue' of England's back-line against Italy
-
Chelsea edge Copenhagen in Conference League last 16 first leg
-
Real Sociedad fight back to earn Man United draw in Europa League
-
Chunky canines: Study reveals dog obesity gene shared by humans
-
Europe rallies behind Zelensky as US announces new talks with Kyiv
-
Drop in US border crossings goes deeper than Trump
-
Guyana appeals to UN court as Venezuelan plans vote in disputed zone
-
Private US spaceship lands near Moon's south pole in uncertain condition
-
Saudi PIF to pay 'up to 12 months maternity leave' for tennis players
-
16 killed in 'most violent' Syria unrest since Assad ouster: monitor
-
Peru farmer confident ahead of German court battle with energy giant
-
US-Hamas talks complicate Gaza truce efforts: analysts
-
European rocket successfully carries out first commercial mission
-
SpaceX gears up for Starship launch as Musk controversy swirls
-
Trump backs off Mexico tariffs while Canada tensions simmer
-
Europe's new rocket blasts off on first commercial mission
-
SpaceX gearing up for Starship launch amid Musk controversy
-
Racked by violence, Haiti faces 'humanitarian catastrophe': MSF
-
Gisele Pelicot's daughter says has filed sex abuse case against father
-
New Zealand set for 'scrap' with India on slower pitch: Santner
-
US signals broader tariff reprieve for Canada, Mexico as trade gap grows
-
US to carry out first firing squad execution since 2010
-
Roy Ayers, godfather of neo-soul, dead at 84
-
ECB chief warns of 'risks all over' as rates cut again
-
Albania to shut down TikTok in coming days
-
Pompidou museum invites public for last look before renovation
-
Graham returns for Scotland's Six Nations match against Wales
-
US firm hours away from Moon landing with drill, rovers, drone
-
Bosnian Serb leader rejects prosecutor summons as crisis deepens
-
England considering Test skipper Stokes for white-ball captaincy

'Fix the system': Indonesia parents seek justice after cough syrup crisis
Dinosaur-themed birthday decorations still hang on the walls of Safitri Puspa Rani's Indonesian home, where the family celebrated their youngest son's birthday last year.
"Knock knock! Hey everyone! It's my eighth birthday!" said a beaming Panghegar Bhumi in a video in September, while making a heart-shaped gesture with his arms.
A month later he died from acute kidney injury, days after a doctor prescribed him a cough syrup containing ingredients that have been linked to more than 200 child deaths in Indonesia, according to the country's health ministry.
"I whispered in his ears: 'The medicine is coming, please hang in there a little bit more'," Rani said, crying in her home in West Java province as she recalled the final days of her son's life.
"But I lied, there was no medicine."
The 42-year-old mother is among more than two dozen Indonesian families seeking justice for their children, whom they allege were either killed or sickened by contaminated cough syrups.
Their class-action lawsuit targets the country's health ministry, food and drug agency, and eight companies they accuse of selling the syrups -- which the World Health Organization said contain an "unacceptable amount" of diethylene glycol and ethylene glycol.
"These contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even taken in small amounts, and should never be found in medicines," the WHO said in January.
Since October last year, the WHO has issued alerts for The Gambia, Indonesia and Uzbekistan over syrups containing the two chemicals.
Five-year-old Farrazka was required to undergo dialysis for his failing kidneys after he took one of the medicines, his mother Indah Septian told AFP.
"When I heard that he had to have dialysis, I was so confused and did not know what to do. He is just a kid," Septian said at her home.
"Now he gets easily fatigued even when he only does a bit of activity," the 31-year-old said.
But Septian and her husband Riski Agri consider themselves luckier than other families.
"Until today I still wake up in the middle of the night and check on him. We almost lost him," 34-year-old Agri said.
- 'Not a priority' -
Since the government sounded the alarm in October, Indonesia's food and drug agency has recalled 105 products after tests revealed excessive amounts of the two chemicals.
It has also revoked the licenses of six pharmaceutical firms.
Police have launched an investigation into five companies and arrested four suspects.
But the plaintiffs say that is not enough.
"From the beginning, this case was not considered a priority," said Awan Puryadi, the lawyer representing the families.
"All of the victims who are still alive, and are still being treated, must all be covered by the government for the rest of their lives."
They are seeking compensation of 2 billion rupiah ($131,000) for every person killed and 1 billion rupiah for every person injured.
In a hearing last month, parents wore black shirts that read "I thought it was medicine, it was poison".
The next hearing is scheduled for March 9.
One of the accused companies in the lawsuit contacted by AFP denied putting the chemicals in its cough syrups and blamed a distributor for any contamination.
Indonesia's drug regulator, like the WHO, says the chemicals should never be used in syrup medicines because they can be toxic for humans.
But it says in the event of contamination during production, the chemicals can be consumed safely up to a level of 0.1 milligrams per millilitre.
Four other companies named in the lawsuit did not respond to a request for comment and AFP was not able to reach three firms. The seven have not commented publicly on the lawsuit or the allegations.
- Expensive treatments -
Without compensation, the injured children's parents face treatment costs that many cannot afford.
Eighteen-month-old Raivan was unable to move after he consumed cough syrup prescribed by a paediatrician in May, said his mother Resti Safriti.
He is now fed through a tube, and breathes through another in his neck.
In the hopes of replicating physical therapy techniques, his parents resort to rocking him on an exercise ball in their Jakarta home.
"We could not afford therapy, so we do what we can with what we have at home," Resti said.
Resti and her husband had to leave their jobs to take care of him, and she begged the government to "fix the system" that has led to her child's suffering.
"Don't let other parents and children go through this," she said. "What if this happened to your own child?"
Ch.Kahalev--AMWN